Nasdaq: NVCT
Nuvectis Pharma insiders
The officers, directors and 10% owners of Nuvectis Pharma, Inc. who hold the most stock, valued at the live NVCT price.
$19.84
NVCT today −$450K (−2.22%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their NVCT stock
- $148M
- Market value
- $680M
- Held by ranked insiders
- 21.7%
Insiders by value of NVCT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Ron Bentsur | Chairman & CEO | 3,688,424 | $73.2M | 10.8% | 1923rd |
| 2 | Enrique Poradosu | Chief Science & Business Off | 1,806,319 | $35.8M | 5.27% | 3269th |
| 3 | Shay Shemesh | Chief Dev. & Ops. Officer | 1,793,068 | $35.6M | 5.23% | 3280th |
| 4 | Kenneth Hoberman | Director | 168,140 | $3.3M | 0.49% | 4911th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Nuvectis Pharma; see each profile for the filing.